Physician profile
Vuong Binh Nguyen
NPI 1093700965
$1,433,580.56
in general payments reported to CMS, 2019-2025
11 companies · $42K in 2025
The $42K reported for 2025 was more than what 91% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $92.98 · 2021: $140 · 2022: $1.3M · 2023: $112K · 2024: $2,149 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $140K · Consulting Fee: $13K · Travel and Lodging: $3,529 · Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $139,674.03 |
| Consulting Fee | $12,500.00 |
| Travel and Lodging | $3,529.03 |
| Food and Beverage | $283.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,346,101.31 | 2019-2025 | Engage Partial Knee System |
| Optimotion Implants, LLC | $85,278.86 | 2022-2024 | Optimotion Implants |
| Ortho Development Corporation | $1,507.67 | 2023 | |
| Stryker Corporation | $242.10 | 2020-2025 | Mako |
| Sonex Health, INC. | $127.35 | 2024 | Sx-One Microknife |
| Nextstep Arthropedix, LLC | $101.79 | 2019 | |
| Medacta USA, INC. | $85.73 | 2021 | |
| Abbvie INC. | $80.71 | 2021-2022 | |
| Allergan, INC. | $42.31 | 2019-2020 | |
| Boston Scientific Corporation | $12.73 | 2023 | Exalt Model D |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$39,516,635.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vuong Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.